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Abstract
Understanding host and pathogen factors that influence tuberculosis (TB) transmission can inform strategies to eliminate the 
spread of Mycobacterium tuberculosis (Mtb). Determining transmission links between cases of TB is complicated by a long and vari-
able latency period and undiagnosed cases, although methods are improving through the application of probabilistic modelling and 
whole- genome sequence analysis. Using a large dataset of 1857 whole- genome sequences and comprehensive metadata from 
Karonga District, Malawi, over 19 years, we reconstructed Mtb transmission networks using a two- step Bayesian approach that 
identified likely infector and recipient cases, whilst robustly allowing for incomplete case sampling. We investigated demographic 
and pathogen genomic variation associated with transmission and clustering in our networks. We found that whilst there was a 
significant decrease in the proportion of infectors over time, we found higher transmissibility and large transmission clusters for 
lineage 2 (Beijing) strains. By performing evolutionary convergence testing (phyC) and genome- wide association analysis (GWAS) 
on transmitting versus non- transmitting cases, we identified six loci, PPE54, accD2, PE_PGRS62, rplI, Rv3751 and Rv2077c, that were 
associated with transmission. This study provides a framework for reconstructing large- scale Mtb transmission networks. We have 
highlighted potential host and pathogen characteristics that were linked to increased transmission in a high- burden setting and 
identified genomic variants that, with validation, could inform further studies into transmissibility and TB eradication.
DATA SummARy
1. All raw Mycobacterium tuberculosis sequence data are avail-
able from the European Nucleotide Archive (ENA) short- read 
archive (project ID ERP000436 and ERP001072).
2. M. tuberculosis strain H37Rv is available from GenBank; 
accession number NC_000962.3.
INTRODuCTION
Establishing patterns of transmission – who infected whom 
– for infectious pathogens is critical for controlling outbreaks 
and informing health management strategies to prevent the 
spread of infection. Tuberculosis (TB), caused by Mycobac-
terium tuberculosis (Mtb), remains a major global health 
concern, responsible for 1.6 million deaths in 2017 alone, 
including nearly 400 000 deaths attributed to HIV- associated 
infection [1]. Despite initiatives aimed at reducing global 
incidence rates, such as the World Health Organization’s ‘End 
TB Strategy’ [1], many regions are falling behind set targets 
for case reduction. Understanding and preventing trans-
mission is fundamental to disease control, but the accurate 
characterization of networks is difficult, especially as the onset 
of active disease follows a long and highly variable latency 
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period during which within- host evolution can occur [2, 3]. 
There is a paucity of long- term studies in high- incidence areas 
[4–7] to assist with providing much needed biological and 
epidemiological insights into transmission.
The Karonga Prevention Study (now Malawi Epidemiology 
and Intervention Research Unit, MEIRU) is based in Karonga 
District in northern Malawi, which has a population of over 
300 000, a high TB incidence (~100 cases per 100 000 popula-
tion) and an HIV prevalence of around 10 % [6, 8]. Since the 
1980s, it has been conducting research on TB in the area, 
collecting sputum specimens from individuals presenting 
at the district hospital and peripheral health centres with 
suspected TB [9, 10]. More than 2100 Mtb DNA samples 
from the mid- 1990s onwards, encompassing strains of the 
major lineages 1–4 [6, 11, 12], have undergone whole- genome 
sequencing (WGS). These genomic data are supported by 
in- depth demographic data, including age, sex, previous 
disease history and HIV status. The combined dataset presents 
a unique opportunity to investigate evolutionary relationships 
among TB patients in a high- incidence area over an extended 
study period (nearly 20 years). The samples collected between 
1995–2010 have previously been used to assess transmission 
using a simple disease outbreak model, allowing up to 10 
single- nucleotide polymorphism (SNP) differences between 
cases [6, 13]. This simple thresholding approach revealed 
decreases in transmission over time and with age, as well 
as lineage differences in transmission [highest in lineage 2 
(East Asian, including Beijing) and lowest in lineage 1 (Indo- 
Oceanic)] [6].
Using an SNP threshold for establishing transmission links is 
suitable for confirming the absence of transmission between 
distant strains, but can be over- simplistic for determining the 
timing and direction of actual transmission events in evolving 
populations [14]. Different thresholds have been applied 
previously across Mtb transmission studies [15–18], and the 
amount of genomic variation in strains can be influenced by 
the culturing protocol and bioinformatics pipeline used to call 
SNPs, making a consensus difficult. Most importantly, it does 
not explicitly allow for missing links in transmission chains.
This study investigated Mtb transmission dynamics in a high- 
TB- burden setting using advanced computational techniques. 
We applied probabilistic modelling to infer high- likelihood 
transmission events in 1857 TB cases from Karonga between 
1995 and 2014. Specifically, the TransPhylo software package 
[3] was employed to provide Bayesian model- based infer-
ence of transmission reconstruction across a time- calibrated 
phylogenetic input, allowing for within- host diversity and 
incomplete sampling to infer the likelihood and time of 
transmission events. By accurately constructing transmis-
sion networks, we aimed to identify demographic factors 
that are associated with: (i) recent transmission; (ii) large, 
persisting transmission clusters; and (iii) transmissibility. 
We also applied phylogenetic convergence testing (phyC) 
and genome- wide association (GWAS) to detect pathogen 
genetic variants that were associated with a transmissible 
phenotype.
mETHODS
Sample collection and preparation
In Karonga District, patients exhibiting symptoms of TB were 
reviewed by project staff at the district hospital and local 
health centres, with those diagnosed with the disease inter-
viewed to obtain further details. The information collected 
included: sex, age and contact with prior TB cases. Patients 
were HIV- tested after counselling and, if consent was given, 
a minimum of three sputum samples were taken from each 
patient. Further details of the study design are available else-
where [8, 9]. The study was approved by the National Health 
Sciences Research Committee in Malawi and by the London 
School of Hygiene and Tropical Medicine ethics committee. 
Informed consent was obtained for all participants.
Sequencing and variant calling
WGS was carried out on >2000 Mtb isolates from Karonga 
(European Nucleotide Archive at EMBL- EBI, study numbers 
ERP000436 and ERP001072). DNA was extracted from a 
sweep of multiple colonies from solid cultures and sequenced 
using the Illumina HiSeq 2000 platform, generating 100 bp 
paired- end reads. Additional culture and sequencing infor-
mation has been provided elsewhere [6]. Quality checking 
of sequenced reads was carried out using FastQC software, 
with adapter sequences and low- quality reads removed using 
Impact Statement
Tuberculosis (TB), caused by Mycobacterium tubercu-
losis, remains a major global health concern, respon-
sible for around 1.64 million deaths globally in 2017, 
with a greater disease burden in high- incidence regions. 
Studies detailing the epidemiological and genetic factors 
influencing TB transmission are complicated by the diffi-
culty of accurately resolving accurate transmission due 
to a variable latency period in which within- host evolu-
tion can occur and low mutation rate. Our work recon-
structs transmission networks in M. tuberculosis cases 
collected as part of a large- scale, long- term study in 
a high- burden region of northern Malawi, applying a 
sophisticated Bayesian approach that incorporates 
parameters for incomplete sampling of the popula-
tion and within- host pathogen evolution to identify risk 
factors associated with recent transmission and onward 
infection. Our approach is of high interest to those using 
genomics in clinical and research settings, in particular 
to the tuberculosis research and clinical communities 
and those investigating outbreaks and pathogen trans-
mission, where the methodological pipeline described in 
our study can be applied in different settings. In addition, 
the risk factors and genomic variants found to be associ-
ated with transmissibility in M. tuberculosis can inform 
further work on tuberculosis transmission and manage-
ment for the spread of infection.
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the Trimmomatic program. Reads were mapped to the Mtb 
H37Rv reference strain (GenBank no.: NC_000962.3) with 
BWA- mem software [19] and SNP and small insertion and 
deletion (INDEL) variants were called using the Samtools 
suite [20]. Low- quality variants (phred score Q<20, read 
depth DP<5) and SNPs found in repeat regions were excluded 
[21]. Variants were removed if there was a missing call (either 
through non- alignment of reads or low coverage) in >10 % 
of samples. Where there were multiple, longitudinal samples 
taken from a patient during the same disease episode of 
disease, the earliest collected sample was used. Samples with 
a high likelihood of mixed infection (two or more concurrent 
Mtb strains) were identified [12] and removed from further 
analysis. In the remaining 1857 samples, heterozygous sites 
were called as the majority allele if there was at least 75 % 
consensus across reads, with a minimum coverage of 20- fold; 
otherwise they were called as missing. Additionally, de novo 
assembly of isolates was carried out with VelvetOptimiser 
[22], a wrapper script that optimizes parameters for the Velvet 
assembler software [23] . Genomes were annotated using 
Prokka [24] and Roary [25].
Phylogenetic analysis
Initially, broad putative clusters of cases were constructed for 
application of the Bayesian transmission inference analysis. 
The clusters were constructed using R software to group cases 
with a maximum pairwise SNP distance threshold of 50 SNPs, 
i.e. a case was included in a cluster if there were ≤50 SNP 
differences from one or more cases within this cluster. The 
threshold to determine potential transmission links between 
patients has previously typically been fixed between 5 and 12 
SNP differences [6, 15, 26], although recent analysis of within- 
patient variation has suggested this estimate may be too low 
[27]. We chose to define broad initial clusters for further 
analysis to allow for missing cases and potential transmission 
between more genetically distant cases.
Phylogenetic trees were assembled for each transmission 
cluster with beast v1.8 [28] using SNP data (excluding 
highly variable PE/PPE and known antimicrobial resistance 
associated genes, and INDELs) and calibrated by episode start 
dates (earliest of specimen collection or registration) at the 
tips. Prior parameters were optimized for each cluster tree by 
performing preliminary analyses with 5×107 Markov chain 
Monte Carlo (MCMC) iterations to determine the substitu-
tion model [Hasegawa, Kishino and Yano (HKY) Gamma; 
generalized time- reversible (GTR) Gamma]; the molecular 
clock (strict; uncorrelated relaxed); and the population size 
and growth (constant; exponential; extended Bayesian skyline 
plot). The performance of each prior parameter iteration was 
assessed through the comparison of posterior marginal like-
lihood estimates and checked for convergence using traces 
of effective sample size (ESS) distributions in Tracer v1.8 
software. Three final runs of 108 MCMC iterations using the 
best fitting prior parameters were combined using LogCom-
biner v1.8, discarding a 10 % burn- in for each run, to reach 
posterior ESS distributions above 200 for each parameter. 
Final maximum clade credibility trees summarizing the 
posterior sample of trees in the combined MCMC runs were 
produced using TreeAnnotator v.1.8 software. Additionally, 
population- level and lineage- specific maximum- likelihood 
(ML) phylogenies were constructed with RAxML [29] using 
the GTR+GAMMA substitution model and 1000 bootstrap 
replicates.
Inferring transmission events
We used the R software package TransPhylo [3] to reconstruct 
transmission within our clusters, allowing for unsampled cases 
and within- host diversity. The program employs a stochastic 
branching process algorithm using the tip- calibrated phylo-
genetic trees as input [28], incorporating information such as 
branch lengths and substitution rates. The algorithm requires 
the user to define model priors estimated from characteris-
tics of the pathogen and sample population, such as genera-
tion time and sampling density, which we tested through a 
sensitivity analysis on two large clusters representing lineage 
2 (n=27) and lineage 3 (n=37) strains. The results of the 
sensitivity analysis and more detailed explanations of the 
rationale behind these prior parameter choices are specified 
in Supplementary Material S2.
The generation time is defined as the time between a host 
becoming infected and infecting another individual, modelled 
as a gamma distribution. This parameter is particularly 
important to define for pathogens with potentially long, vari-
able periods of latency, such as Mtb, where the time between a 
host becoming infected and infecting others can range from a 
few weeks to many years [2]. Due to this highly variable latent 
and infectious period in Mtb infections, we set a wide genera-
tion time gamma distribution with a median of 3.9 years and 
a long tail (gamma shape=2.2, scale=2.1, rate=0.48).
Prior values for the sampling interval (the time between the 
onset of infection and the sample collection date, modelled 
with a gamma distribution), sampling density (π), basic repro-
ductive number (R) and within- host effective population size 
(Neg), were also specified to refine the biological relevance 
of the model. The sampling interval prior distribution was 
chosen to be the same as the generation time (median of 
~3.9 years; gamma shape=2.3, scale=2.1) as the time from 
diagnosis to end of infectiousness is short compared to the 
latent period (Supplementary Material S2). We set R=1.75 
[estimated from the sensitivity analysis (Supplementary Mate-
rial S2)] and Neg=1.48 (based on a previous study [14]), with 
these two values being updated through MCMC iterations. 
Finally, we chose to test a fixed sampling density of π=0.5 
based on the results of sensitivity analysis and allowing for 
unsampled cases through the unavailability of WGS data or 
undiagnosed cases.
The algorithm was applied to each cluster for 5×105 MCMC 
iterations, sampling every 10 000 states, with a 10 % burn- in, 
and convergence- tested through inspection of trace plots 
of effective sample size (ESS). Transmission links with a 
posterior probability of more than 0.5 were accepted and 
the direction was inferred by using the highest probability 
where links in both directions were accepted. Where more 
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than one potential infector case was inferred for the same 
recipient, the transmission link with the highest probability 
was taken. We accounted for the evidence that transmission 
from patients with extrapulmonary TB is highly unlikely [30] 
by excluding these links. Manual inspection of small INDEL 
profiles between linked cases and tracing of epidemiological 
links between cases (where available) were used to confirm 
transmission links and the direction of transmission.
Transmission networks and demographic 
associations
We characterized the final set of transmission networks 
as including cases either directly linked or with up to two 
unsampled hosts between the transmission events inferred 
through the TransPhylo analysis. The host demographic 
and epidemiological metadata collected with each case were 
analysed for significant associations with recent infection 
(transmission within previous 3 years, first 3 years of data 
collection excluded), large clusters (≥10 sampled cases and 
≥1 case per year) and transmissibility (cases transmitting to 
a recipient within 4 years versus single cases, last 4 years of 
data collection excluded), through logistic regression. These 
metadata included major lineage, age, sex, collection date, 
HIV status, treatment outcome, birthplace, recent residence, 
and isoniazid and rifampicin resistance.
Genomic variant analysis
SNPs associated with transmissibility were identified by 
applying phyC, a test for detecting shared variants among 
groups through evolutionary convergence [31], comparing 
infector TB cases (cases transmitting to a recipient within 
4 years) against the cases not found in a transmission cluster. 
We tested for sites that were associated with transmissibility in 
separate lineages and across the whole population. The likeli-
hood of association was established by significance testing 
with Fisher’s exact test (P<0.05 [31]). A complementary 
mixed model GWAS approach [32] was also conducted to 
reveal any SNPs or loci highly associated with transmitting 
cases, including an analysis of aggregated numbers of non- 
synonymous mutations per gene. A significance threshold 
of P<10−5 was assigned by applying a Bonferroni correction 
for multiple testing. All analyses were performed in R and 
Python.
RESuLTS
Mtb lineages
High- quality WGS data were available for 2129 Mtb genomes 
collected between 1995 and 2014. Multiple samples from the 
same individual during the same disease episode or through 
likely relapse [11] (n=77) or with a high likelihood of mixed 
infection (n=195) [12] were removed from further analysis, 
resulting in 1857 isolates being used in our analysis. The 
majority of isolates belonged to major lineage 4 (1279 isolates; 
68.7 %), followed by lineages 1 (n=290; 15.6 %), 3 (n=217; 
11.6 %) and 2 (n=71; 3.8 %) (Fig. 1a), with their proportions 
changing through the study period, but lineage 4 strains 
always being predominant (Fig. 1b). There were differences in 
diversity among strains of different major lineages, with line-
ages 2 and 3 being characterized by the least pairwise diversity 
[median=82 SNPs (interquartile range, IQR, 59–128) and 
130 SNPs (IQR 21–137), respectively], followed by lineage 
4 [median=198 SNPs (IQR 94–339)] and lineage 1 with the 
highest diversity between isolates [median=424 SNPs (IQR 
167–491)] (Fig. 2a).
Transmission networks
We found that 1355 isolates (73.0 %) were clustered into 
281 transmission networks (or 57.8 % of isolates using the 
n-1 method removing the index case [33]) after removing 
likely relapse cases as previously described [11]. Fig. 3 shows 
an example of an inferred transmission network. Lineage 2 
strains had the highest clustering rate (69/71 strains; 97.2 %), 
followed by lineage 3 (178/217 strains; 82.0 %), lineage 4 
(911/1279; 71.2 %) and lineage 1 (197/290; 67.9 %). Cluster 
sizes ranged from 2 to 51 samples (median 3 cases, IQR 2–5) 
and were largest for lineage 2 strains (median 4 cases, IQR 
4–12) (Fig. 2b). Strains belonging to lineage 1 were found in 
the smallest clusters (median 3 cases, IQR 2–4) with the highest 
genetic diversity (3.75 SNPs; IQR 1–5) (Fig. 2c). Lineage 4 had 
the lowest genetic diversity within clusters (median 2 SNPs, 
IQR 1–3.25), although this was not significantly different 
from lineage 2 and 3 clusters (Wilcoxon P=0.15 and 0.54, 
respectively) and was likely due to the significantly smaller 
average cluster size (Wilcoxon P<0.01).
We identified 544 direct transmission events between sampled 
cases (i.e. with no inferred unsampled host in- between), as 
detailed in the Supplementary Material S1. The time between 
direct transmission events ranged from 41 days to 12.4 years, 
with a median of 1.7 years (IQR 0.9–3.2 years). The median 
SNP difference between cases inferred to be linked by a direct 
transmission event was relatively low, with a median of 0 SNPs 
(IQR 0–1), and this was consistent between direct transmis-
sions in different lineage clusters (Fig. 2d). The number of 
SNP differences between directly linked cases ranged from 0 
to 12 SNPs, although the majority of cases differed by fewer 
than 5 SNPs (99.1 %). We also found no INDEL differences 
between directly linked cases.
Recent infection
Recent infection was defined as transmission links for which 
the source case was within 3 years of the recipient, estimated 
by TransPhylo. Cases occurring before 1999 were excluded 
to ensure that the prior 3 years of data were available. We 
found that 49.4 % of cases showed evidence of recent infection 
(Table 1), with lineage 2 cases having the highest proportion 
(71.9 %) and lineage 1 (39.6 %) the lowest. We also found 
significant associations with age, with a higher proportion of 
recent infection in the younger age groups but no significant 
reduction in the proportion of recent infection over time.
The risk of recent infection was higher in patients who had had 
a previous episode of TB [odds ratio adjusted for age, sex, year 
and lineage (aOR)=2.0 (95 % CI: 1.4–2.9; P<0.01)] compared 
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Fig. 1. (a) Maximum- likelihood phylogenetic tree of the 1857 Karonga strains used in this study, showing lineages clustering into 
monophyletic groups. Lineage 1 is shown in blue, lineage 2 in red, lineage 3 in green and lineage 4 in orange. (b) The total number of 
sequenced cases and the proportion of strains collected, by lineage, over the study period 1995–2014 in 4- year categories.
to no previous episode. Recent infection was also lower in 
patients from outside Karonga district (though this may be 
due to sampling bias as the source of infection is less likely 
to be captured as it may be outside the sample population), 
and higher in patients with isoniazid- resistant Mtb [aOR=1.6 
(95 % CI 1.0–2.5; P=0.01)]. There was also some evidence of 
a lower proportion of recent infection in extrapulmonary TB 
cases [aOR=0.5 (95 % CI 0.3–1.0; P=0.06] compared to smear- 
positive cases and in patients who were subsequently lost or 
transferred versus those completing treatment or who died.
By increasing the number of years from 3 to 5 to characterize 
recent infection, all associated factors identified with recent 
infection at 3 years were also found (Supplementary Material 
S2, Table S1). In addition, we found that HIV- positive patients 
were more likely to have recent infection than HIV- negative 
patients.
Large clusters
Cases within large, persistent transmission clusters (>10 cases 
and a rate of >1 case per year, Fig. 4) were compared to small 
clusters (<5 cases) and unclustered cases. This resulted in 23 
large clusters of between 10 and 51 cases. Intermediate- sized 
clusters (>10 cases but <1 case per year, or between 5 and 10 
cases) were excluded from this analysis to allow for a more 
distinct comparison. Clusters with the earliest collection date 
after 2010 were also excluded as these may have the potential 
to continue growing into larger clusters after the study period.
Lineage 2 strains were significantly more likely to be found 
in large clusters [aOR=3.4 (95 % CI 1.9–6.3)], compared to 
lineage 4. The oldest patients (50+ years) were least likely to 
have large cluster strains. Residence within Karonga district 
was associated with large cluster strains, though again this 
is likely due to sampling bias, as cases within a cluster from 
outside the Karonga district would not be captured within 
our sample population. Additionally, there was some evidence 
that HIV- negative patients and those with rifampicin- resistant 
Mtb strains were less likely to be in large clusters (Table 2).
Transmissibility
Infectors were defined as cases that were inferred to have 
transmitted Mtb to either sampled or unsampled cases. Demo-
graphic factors associated with these cases were compared to 
those with no onward transmission. Extrapulmonary cases, 
and those seen after 2010, which may transmit after the study 
period, were excluded. Four hundred and sixty- eight out of 
1556 (30.1 %) cases seen before 2011 transmitted Mtb to at 
least 1 person; and 369 (23.7 %) transmitted with a serial 
interval of 4 years or less. Most infectors that transmitted 
within 4 years were responsible for a single onward transmis-
sion (80.2 %), with the number of secondary cases caused by 
infectors ranging from 1 to 6.
Table 3 shows the demographic associations with transmis-
sion to another case within 4 years, applying ordered logistic 
regression in relation to the number of secondary cases 
6Sobkowiak et al., Microbial Genomics 2020;6
Fig. 2. (a) Pairwise SNP distance by lineage between all Karonga strains used in the study. (b) Transmission cluster size by lineage, 
excluding non- clustered individuals. Clusters are defined as sampled strains (excluding non- sampled cases) linked either through direct 
transmission or with up to two transmission events inferred between individuals. P- values are a comparison against lineage 4 using 
the Wilcoxon rank sum test. (c) Median SNP distance in transmission clusters (sampled cases only). P- values are a comparison against 
lineage 4 using the Wilcoxon rank sum test. (d) Pairwise SNP distance between individuals in direct transmission events. P- values are a 
comparison against lineage 4 using the Wilcoxon rank sum test.
caused by each infector. There were lineage differences asso-
ciated with transmissibility, with lineage 2 strains the most 
likely to transmit and those from lineage 1 the least likely. The 
proportion of infector cases in the total population decreased 
significantly per year throughout the duration of the study 
period (P<0.05) (Supplementary Material S2, Fig. S1). 
Patients under 50 years of age and those with smear- positive 
disease were more likely to transmit. Patients who died or 
were transferred/lost to follow- up, those with isoniazid resist-
ance and those born outside Karonga District were less likely 
to transmit. Associations were similar when comparing all 
transmission events, not restricting to those giving rise to 
cases within 4 years (Supplementary Material S2, Table S2).
Genomic associations with transmission
We used two complementary approaches to search for genetic 
variants associated with transmission, convergence testing 
(phyC) and GWAS analysis. We considered both individual 
SNPs and whole- gene variation (through aggregated SNPs) 
to identify significant differences between variants found 
in transmitting versus non- transmitting strains. Non- 
transmitted strains were classified as singletons that were not 
included in any transmission cluster (n=409), again excluding 
extrapulmonary strains and cases collected after 2010. 
Transmitted strains were defined as strains from cases that 
transmitted to at least one other host within 4 years (n=369). 
SNPs identified in known antimicrobial resistance loci and 
PE/PPE genes, which were excluded in the transmission 
network analysis, were also considered to determine if these 
sites were associated with a transmissible phenotype. We also 
looked for convergent evolution in the presence or absence of 
small INDELs in the transmitter and non- transmitter groups.
The phyC analysis revealed no SNPs or whole genes that 
were convergently evolved in transmissible Mtb strains in 
our population. We also applied the analysis to lineage 1 and 
4 strains separately (sample sizes in lineages 2 and 3 were too 
small to analyse) and no significant lineage- specific associa-
tions were identified. We found significant convergent evolu-
tion in a four- codon deletion in PPE54 (P=0.01, Table 4), a 
PE/PPE gene that has been proposed to be associated with 
antibiotic resistance through gene–gene interactions with 
other resistance loci [34], and in host–pathogen interactions 
[35].
A GWAS analysis revealed variants that are potentially 
linked to transmissibility (Table  4). The most statistically 
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Fig. 3. An example transmission network of lineage 2 strains reconstructed with TransPhylo software. Sampled cases are illustrated by 
filled dots and non- sampled, inferred intermediate hosts are indicated with unfilled dots. The direction of transmission is from left to 
right with the transmission date on the x- axis.
significant variant was the synonymous SNP A31A in Rv3751, 
a non- essential gene coding for a probable phage integrase 
(P=8.8×10−5). We found two further loci that were found to 
be less significantly associated with transmissibility in our 
data (P<10−4), a non- synonymous mutation N125H in accD2 
encoding an acetyl- CoA carboxylase subunit and the PE/PPE 
gene Rv3812 identified through the gene- level, aggregated- 
mutation GWAS. In addition, we found fewer significant 
associations (P<10−4) in a 3 bp deletion in Rv2077c, a possible 
transmembrane protein, and a 3 bp insertion in rplI, which 
codes for the 50 s ribosomal protein L9. Five genomic regions 
previously identified as being involved in transmission in 
a low- burden setting [36] were not validated in our study 
(P>0.05; Supplementary Material S2, Table S3).
DISCuSSION
Accurate reconstruction and analysis of TB transmission 
networks can provide insights into the factors that can influ-
ence the spread of the infection. Here we present a compre-
hensive large- scale study of transmission in a high- incidence 
region. We applied a sophisticated two- step Bayesian approach 
to reconstruct TB transmission networks from WGS data, 
allowing for within- host evolution and non- sampled hosts 
between sampled cases [3], the absence of which has been a 
limitation in previous studies.
The characteristics of the resulting transmission networks 
are consistent with a population with some latent infection, 
with a median generation time between transmission events 
of 1.7 years (IQR 0.9–3.2 years). The median distance between 
directly linked cases ranged from 0 to 12 SNPs, supporting 
a previous estimate found in this population between index 
patients and their identified prior contacts [8]. Network 
reconstruction has allowed us to gain further insights into 
the demographic factors associated with transmission in this 
setting and identify genomic variants that may be associated 
with transmissibility.
There are limitations with the methods used to infer transmis-
sion events and identify infector strains. While intermediate 
hosts between sampled cases were inferred, transmission 
from a sampled case to a non- sampled case that does not 
transmit onwards would not be captured and, in this scenario, 
the sampled case will not be characterized as an infector. 
Furthermore, our measure of transmission is necessarily 
time- limited: disease may occur up to a lifetime after infec-
tion, whereas we have taken a 4- year window, so underes-
timating transmission. However, the approach used in this 
study is a huge step towards a more complete reconstruction 
of transmission to reveal associated risk factors, including 
in cohorts with incomplete sampling, which can be used to 
prioritize patients and their contacts with a high possibility 
of onward transmission.
We found clear lineage differences in transmissibility and 
recent infection in our population, with lineage 2 strains 
exhibiting the greatest proportion of recently infected cases 
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Table 1. Demographic characteristics associated with recent infection, defined as cases for whom the source of infection has been inferred within the 
last 3 years. Cases prior to 1999 are excluded. Odds ratios and P- values are calculated through logistic regression and Wald chi- Squared test, adjusted 
for age, sex, year and lineage
Recent infection/total % recent infection Odds ratio (95 % CI) P- value
Year
  1999–2001 181/367 49.3 1
  2002–2004 171/379 45.1 0.9 (0.6–1.2)
  2005–2007 137/298 46.0 0.9 (0.7–1.2)
  2008–2010 93/219 42.5 0.8 (0.5–1.1)
  2011–2014 108/219 49.3 1.0 (0.7–1.4) 0.52
Lineage
  1 86/232 37.1 0.7 (0.5–0.9)
  2 46/64 71.9 2.8 (1.7–5.1)
  3 88/187 47.1 1.0 (0.7–1.4)
  4 470/999 47.0 1 <0.01
Age group (years)
  <20 33/64 51.6 1.8 (1.0–3.1)
  20–29 204/370 55.1 2.1 (1.5–2.9)
  30–39 236/528 44.7 1.4 (1.0–1.9)
  40–49 132/290 45.5 1.4 (1.0–2.0)
  50+ 85/230 37.0 1 <0.01
Sex
  Female 361/752 48.0 1
  Male 329/730 45.1 0.9 (0.7–1.1) 0.33
HIV status
  Negative 235/514 45.7 1
  Positive on ART 64/123 52.0 1.3 (0.8–1.9)
  Positive no ART 274/584 46.9 1.1 (0.8–1.3) 0.51
Previous TB
  Yes 101/167 60.5 1.9 (1.4–2.6)
  No 589/1315 44.8 1 <0.01
TB type
  Smear positive 540/1144 47.2 1
  Smear negative 135/294 45.9 0.9 (0.7–1.2)
  Extrapulmonary 15/44 34.1 0.5 (0.3–1.0) 0.09
Outcome
  Completed 485/1023 47.4 1
  Died 144/286 50.3 1.1 (0.9–1.5)
  Lost/transferred 55/149 36.9 0.6 (0.4–0.9) 0.02
Isoniazid Resistance
Continued
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Recent infection/total % recent infection Odds ratio (95 % CI) P- value
  Resistant 59/99 59.6 1.8 (1.2–2.7)
  Sensitive 609/1313 46.4 1 <0.01
Rifampicin resistance
  Resistant 5/12 41.7 0.7 (0.2–2.2)
  Sensitive 664/1399 47.5 1 0.65
Recent Residence
  Karonga 571/1158 49.3 1
  Other Malawi 84/228 36.8 0.6 (0.4–0.8)
  Other country 21/66 31.8 0.5 (0.3–0.8) <0.01
Birthplace
  Karonga 453/906 50.0 1
  Other Malawi 121/300 40.3 0.7 (0.5–0.9)
  Other country 102/252 40.5 0.7 (0.5–0.9) <0.01
ART, antiretroviral therapy.
Table 1. Continued
Fig. 4. Cluster size by the number of cases per year (calculated as the date range of a cluster divided by the number of cases) in clusters 
with ≥five cases. Large clusters are defined as clusters of ≥10 cases and >1 case per year (red dashed lines), and are shown in the upper 
right quadrant of the figure.
and the highest transmissibility, followed by lineage 3 strains. 
These lineages were also characterized by larger transmis-
sion clusters of cases with low genetic diversity. Increased 
transmission of lineage 2 strains, particularly in the Beijing 
subtype, has been reported in previous work in the Karonga 
population [6], as well as studies in other regions [37–39]. 6 
In this study though, we do not see evidence that lineage 2 
strains increase in frequency, with a peak frequency early in 
study period around 1999–2002. This may be driven by high 
local transmission in a small number of lineage 2 clusters 
with few imported cases that are persisting in the study area, 
in contrast to lineage 4 strains that are more dominant in the 
region and account for the majority of imported cases from 
outside Karonga [6], and thus will include a greater number of 
unlinked cases. Lineage 1 strains were found in small clusters 
composed of significantly more diverse strains and were the 
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Table 2. Demographic characteristics associated with large clusters (cases in clusters of ≥10 cases and >1 case per year). Cases in clusters ≥10 cases 
but <1 case per year, and cases in clusters with the index case after 2010, are excluded. Odds ratios are calculated through logistic regression and 
P- values by the Wald chi- squared test, adjusted for age, sex, year and lineage
Large clusters/total % large clusters Odds ratio (95 % CI) P- value
Year
  1995–1998 81/304 26.6 1
  1999–2001 80/302 26.5 1.0 (0.7–1.4)
  2002–2004 95/303 31.4 1.2 (0.9–1.8)
  2005–2007 82/247 33.2 1.4 (0.9–2.0)
  2008–2010 57/184 31.0 1.2 (0.8–1.8)
  2011–2014 52/188 27.7 1.0 (0.7–1.5) 0.39
Lineage
  1 69/257 26.8 0.9 (0.7–1.3)
  2 27/47 57.4 3.4 (1.9–6.3)
  3 59/176 33.5 1.3 (0.9–1.8)
  4 292/1048 27.9 1 <0.01
Age group (years)
  <20 23/68 33.8 1.9 (1.0–3.4)
  20–29 130/403 32.6 1.8 (1.2–2.6)
  30–39 155/527 29.4 1.5 (1.1–2.2)
  40–49 89/299 29.8 1.5 (1.0–2.3)
  50+ 50/231 21.6 1 0.05
Sex
  Female 220/761 28.9 1
  Male 227/767 29.6 1.0 (0.8–1.3) 0.80
HIV status
  Negative 131/503 26.0 1
  Positive on ART 40/108 37.0 1.6 (1.0–2.6)
  Positive no ART 187/583 32.1 1.3 (1.0–1.8) 0.08
Previous TB
  Yes 55/148 37.2 1.5 (1.0–2.1)
  No 392/1380 28.4 1 0.12
TB type
  Smear- positive 254/818 31.1 1
  Smear- negative 79/294 26.9 0.9 (0.6–1.1)
  Extrapulmonary 37/163 22.7 0.8 (0.4–1.3) 0.38
Outcome
  Completed 307/1003 30.6 1
  Died 96/315 30.5 1.0 (0.8–1.3)
  Lost/transferred 43/190 22.6 0.7 (0.5–1.0) 0.11
Continued
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Large clusters/total % large clusters Odds ratio (95 % CI) P- value
Isoniazid resistance
  Resistant 24/99 24.2 0.7 (1.0–1.2)
  Sensitive 408/1366 29.9 1 0.20
Rifampicin resistance
  Resistant 1/15 6.7 0.2 (0.0–0.9)
  Sensitive 432/1451 29.8 1 0.09
Recent residence
  Karonga 360/1114 32.3 1
  Other Malawi 51/248 20.6 0.5 (0.4–0.8)
  Other country 16/89 18.0 0.5 (0.3–0.8) <0.01
Birthplace
  Karonga 281/907 31.0 1
  Other Malawi 85/315 27.0 0.8 (0.5–1.1)
  Other country 69/264 26.1 0.8 (0.6–1.1) 0.21
ART, antiretroviral therapy.
Table 2. Continued
least transmissible, with the lowest proportion of recent infec-
tion. This supports evidence that lineage 1 strains, which are 
considered ‘ancient’, have lower virulence than the ‘modern’ 
lineages 2, 3 and 4 [40].
The decrease in transmission by calendar year reported previ-
ously up to the year 2010 [6] is confirmed in this new analysis 
and has continued from 2011 to 2014, though surprisingly it 
is not seen in the proportion of disease due to recent infection 
in the latest period. The lowest proportion of recent infection 
and transmission was found in those aged more than 50 years 
and this may reflect an increase in relapse shown previously 
[11], or the higher risk of reactivation due to a weakened 
immune system with age [41], or the lower chance of catching 
or spreading the infection as mobility and contact outside the 
home decreases.
We also looked at the underlying factors that characterize 
larger, persistent transmission clusters that have been circu-
lating in the population over a long period, defined as clusters 
with >10 cases transmitting at a rate of >1 case per year. The 
associations with age, lineage and residence were similar to 
those found in other analyses [42]. Interestingly, HIV- positive 
patients were more likely to have large cluster strains, whereas 
the evidence of association between HIV infection and recent 
infection was weaker. It is possible that nosocomial transmis-
sion in HIV testing and treatment centres has contributed to 
these clusters [43]. Although it has been suggested that HIV- 
positive patients transmit less than HIV- negative patients, 
because they tend to be diagnosed earlier or die quickly, we 
found no evidence of reduced transmission.
Comparing the full genomic variation in strains that have 
been identified as transmitting to at least one recipient against 
cases with no evidence of onward transmission, we were able 
to look for possible mutations that were positively associated 
with transmissible strains. Two complementary methods, 
phyC and GWAS, were employed to test for differences 
between these groups, both in single- site mutations (SNPs 
and INDELS) and in aggregated mutation differences within 
whole genes. The GWAS approach revealed SNPs in Rv3751, 
accD2, Rv3812, rplI and Rv2077c as potentially associated 
with transmissibility. Members of the accD gene family have 
been linked to persistence of the Mtb bacterium [44]. The 
PE/PPE gene Rv3812 has a role in the host immune response 
and virulence of the pathogen [45]. The phyC evolutionary 
convergence approach revealed a 12 bp deletion within PPE54, 
validated through manual inspection of alignment files and de 
novo assemblies of isolates, which is an important gene for in 
vitro growth and host–pathogen interactions [35], as well as 
isoniazid and rifampicin resistance [34].
Previous work using a phyC approach identified five genomic 
regions involved in transmission in a low- burden setting in the 
Netherlands. None were validated in our analysis, although 
we did have poor sequencing coverage in Rv2815–2816 c and 
Rv3512, so we can not explicitly rule out a role in transmis-
sibility within our population (Supplementary Material S2, 
Table S3). These differences may be explained by disease 
burden (low- burden vs high- burden setting), methodologies 
(the transmissibility phenotype in the Netherlands popula-
tion was defined using a combination of clustering through 
DNA fingerprinting and a measure of transmission risk using 
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Table 3. Demographic characteristics associated with infector cases that have transmitted to another sampled or non- sampled case within 4 years. 
Cases collected after 2010 and extrapulmonary cases are excluded. Odds ratios are calculated through ordered logistic regression by number of 
secondary infections, and P- values by the Wald chi- squared test, adjusted for age, sex, year and lineage
Infector /total % infectors Odds ratio (95 % CI) P- value
Year
  1995–1998 99/337 29.4 1
  1999–2001 95/346 27.5 0.9 (0.6–1.2)
  2002–2004 89/367 24.3 0.8 (0.6–1.1)
  2005–2007 61/288 21.2 0.6 (0.4–0.9)
  2008–2010 25/218 11.5 0.3 (0.2–0.5) <0.01
Lineage
  1 48/243 19.8 0.8 (0.6–1.2)
  2 20/61 32.8 1.6 (0.9–2.7)
  3 48/185 25.9 1.4 (0.9–1.8)
  4 253/1067 23.7 1 0.05
Age group (years)
  <20 13/55 23.6 1.6 (0.7–3.2)
  20–29 116/411 28.2 2.1 (1.4–3.2)
  30–39 132/547 24.1 1.8 (1.2–2.7)
  40–49 69/290 23.8 1.8 (1.2–2.8)
  50+ 39/253 15.4 1 0.01
Sex
  Female 206/815 25.3 1
  Male 163/741 22.0 0.8 (0.7–1.1) 0.18
HIV status
  Negative 112/469 23.9 1
  Positive on ART 14/78 17.9 1.0 (0.5–1.9)
  Positive no ART 155/639 24.3 1.0 (0.7–1.3) 1.0
  Previous TB
  Yes 35/171 20.4 0.9 (0.6–1.3)
  No 334/1385 24.1 1 0.43
TB type
  Smear- positive 329/1218 27.0 1
  Smear- negative 40/338 11.8 0.4 (0.2–0.5) <0.01
Outcome
  Completed 262/1011 25.9 1
  Died 67/337 19.9 0.6 (0.5–0.9)
  Lost/transferred 40/191 20.9 0.7 (0.4–1.0) <0.01
Isoniazid Resistance
  Resistant 19/108 17.6 0.6 (0.4–1.0)
Continued
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Infector /total % infectors Odds ratio (95 % CI) P- value
  Sensitive 347/1402 24.8 1 0.07
Rifampicin resistance
  Resistant 2/15 13.3 0.5 (0.1–1.8)
  Sensitive 363/1495 24.3 1 0.36
Recent residence
  Karonga 263/1131 23.3 1
  Other Malawi 59/247 23.9 1.0 (0.7–1.3)
  Other country 20/90 22.2 0.8 (0.5–1.4) 0.78
Birthplace
  Karonga 242/942 25.7 1
  Other Malawi 52/299 17.4 0.6 (0.4–0.8)
  Other country 66/281 23.5 0.9 (0.6–1.2) 0.02
ART, antiretroviral therapy
Table 3. Continued
Table 4. Genomic variants related to transmissibility identified through evolutionary convergence testing (phyC) and genome- wide association study 
(GWAS) mixed model approach (SNPs) and aggregated mutation mixed model (gene)
Locus tag Gene name Function P- value Identification method SNP, gene, insertion or deletion
Rv3343c PPE54 PE/PPE gene 0.01 phyC Δ12 bp deletion
Rv3751 . Probable integrase 8.8×10−5 GWAS S* SNP (A31A)
Rv0974c accD2 Acetyl- CoA carboxylase 2.6×10−4 GWAS NS** SNP (N125H)
Rv3812 PE_PGRS62 PE/PPE gene 3.1×10−4 GWAS Gene
Rv0056 rplI 50S ribosomal protein L9 3.9×10−4 GWAS Δ3 bp insertion
Rv2077c . Possible transmembrane protein 6.2×10−4 GWAS Δ3 bp deletion
*, synonymous; **, non- synonymous.
demographic features) and genetic variability within the two 
sample populations [36].
In general, any loci associated with transmissibility need 
to be validated in other cohorts and settings, and experi-
mentally. Our dataset contained few lineage 2 and 3 strains 
that did not cluster in transmission networks, limiting our 
ability to conduct lineage- specific association tests. The 
higher transmission found in these lineages may be driven 
by lineage- specific genomic variation that may be revealed 
by testing cohorts with a high proportion of lineage 2 and 3 
strains, including those sourced from East Asia and the Indian 
subcontinent. Putative variants found to be associated with 
transmissibility through genomic analysis can be experimen-
tally validated using the CRISPR/cas9 system, with methods 
specific to gene modification in Mycobacterium species begin-
ning to be developed [46].
There is a body of evidence to suggest that successful 
transmission and virulence in Mtb can be affected by 
mutation in key resistance- conferring genes, with both 
higher and lower levels of transmission depending on 
the setting and strain resistance profiles [47–50]. In this 
analysis, isoniazid- resistant strains were less likely to 
transmit but more likely to be due to recent transmission, 
but there were few rifampicin- resistant strains. It is also 
likely that in a high- burden setting host demographic and 
genetic factors will play a larger role in disease suscep-
tibility, the spread of infection and the development of 
disease as individuals will be exposed to higher levels of 
contact with potentially infectious individuals [51, 52]. As 
such, the likelihood of transmission from host to recipient 
is not isolated to the pathogenic virulence and fitness 
but also to host–pathogen interactions, and this may go 
towards explaining the small number of Mtb genes found 
to be associated with transmission in our population. 
Incorporating host genome differences and interactions 
with pathogen in work of this nature would offer a more 
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complete understanding of the underlying factors influ-
encing the spread of Mtb.
CONCLuSIONS
Our work applied a sophisticated Bayesian approach to 
reconstruct TB transmission networks with high confi-
dence in high- burden settings, using WGS data from a 
large- scale, long- term study. It has built upon a previous 
study detailing transmission in the region [6] by extending 
the study for a longer period and updating the methods 
for transmission reconstruction using recent advances. We 
have validated previous findings to support increased trans-
missibility of lineage 2 and 3 strains. In addition, we found 
evidence that differences in age and lineage can influence 
the likelihood of large, persistent transmission clusters. 
We identified three potential genes that may be associ-
ated with transmissible strains of Mtb based on significant 
associations with transmissibility in our population and 
previous studies on their function [34, 35, 44, 45], which 
can be used as potential target sites for further validation 
studies. While this work highlights the complex nature of 
identifying the drivers of transmission in TB populations, 
the methods applied can be used as a framework for future 
studies, where ideally both host and pathogen genomic 
components should be integrated. Ultimately, any insights 
gained into genetic and non- genetic factors linked to 
transmissibility have the potential to inform much- needed 
disease control and management strategies to reduce the 
spread of TB globally.
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